CV Lattes
ORCID
Abstract
Background: Several studies aim to improve the diagnosis and treatment of melanoma, emphasizing immunotherapy due to its significant contribution to improving the prognosis in these patients. However, half of patients with metastatic melanoma do not obtain durable survival benefits, motivating the search for markers that identify non-responsive patients. Although histopathological evaluat…